Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Hematological phenotypes in children according to the α-globin genotypes.

Origa R, Barella S, Paglietti ME, Anni F, Danjou F, Denotti AR, Desogus MF, Loi D, Orecchia V, Sollaino MC, Moi P.

Blood Cells Mol Dis. 2018 Mar;69:102-106. doi: 10.1016/j.bcmd.2017.10.003. Epub 2017 Nov 3.

PMID:
29162392
2.

Hypothermic pulsatile preservation of kidneys from uncontrolled deceased donors after cardiac arrest - a retrospective study.

Matillon X, Danjou F, Petruzzo P, Thaunat O, Rimmele T, Delsuc C, Faure A, Rabeyrin M, Meas Yedid V, Hanf W, Morelon E, Badet L, Codas R.

Transpl Int. 2017 Dec;30(12):1284-1291. doi: 10.1111/tri.13024. Epub 2017 Sep 12.

3.

A genome-wide association study by ImmunoChip reveals potential modifiers in myelodysplastic syndromes.

Danjou F, Fozza C, Zoledziewska M, Mulas A, Corda G, Contini S, Dore F, Galleu A, Di Tucci AA, Caocci G, Gaviano E, Latte G, Gabbas A, Casula P, Delogu LG, La Nasa G, Angelucci E, Cucca F, Longinotti M.

Exp Hematol. 2016 Nov;44(11):1034-1038. doi: 10.1016/j.exphem.2016.07.005. Epub 2016 Jul 21.

PMID:
27449989
4.

Current growth patterns in children and adolescents with thalassemia major.

Origa R, Danjou F, Orecchia V, Zappu A, Dessì C, Foschini ML, Leoni GB, Moi P, Morittu M, Demurtas A, Loche S.

Blood. 2016 Nov 24;128(21):2580-2582. Epub 2016 Oct 13. No abstract available.

5.

Valeur pronostique de l'index de résistance lors de la conservation rénale pulsatile hypothermique des greffons prélevés à partir de donneurs décédés après arrêt cardiaque.

Matillon X, Codas R, Danjou F, Petruzzo P, Morelon E, Martin X, Badet L.

Prog Urol. 2014 Nov;24(13):803. doi: 10.1016/j.purol.2014.08.046. Epub 2014 Oct 30. French. No abstract available.

PMID:
26461573
6.

The V736A TMPRSS6 polymorphism influences liver iron concentration in nontransfusion-dependent thalassemias.

Cau M, Danjou F, Chessa R, Serrenti M, Addis M, Barella S, Origa R.

Am J Hematol. 2015 Dec;90(12):E225-6. doi: 10.1002/ajh.24197. Epub 2015 Nov 17. No abstract available.

7.

Genome sequencing elucidates Sardinian genetic architecture and augments association analyses for lipid and blood inflammatory markers.

Sidore C, Busonero F, Maschio A, Porcu E, Naitza S, Zoledziewska M, Mulas A, Pistis G, Steri M, Danjou F, Kwong A, Ortega Del Vecchyo VD, Chiang CWK, Bragg-Gresham J, Pitzalis M, Nagaraja R, Tarrier B, Brennan C, Uzzau S, Fuchsberger C, Atzeni R, Reinier F, Berutti R, Huang J, Timpson NJ, Toniolo D, Gasparini P, Malerba G, Dedoussis G, Zeggini E, Soranzo N, Jones C, Lyons R, Angius A, Kang HM, Novembre J, Sanna S, Schlessinger D, Cucca F, Abecasis GR.

Nat Genet. 2015 Nov;47(11):1272-1281. doi: 10.1038/ng.3368. Epub 2015 Sep 14.

8.

Genome-wide association analyses based on whole-genome sequencing in Sardinia provide insights into regulation of hemoglobin levels.

Danjou F, Zoledziewska M, Sidore C, Steri M, Busonero F, Maschio A, Mulas A, Perseu L, Barella S, Porcu E, Pistis G, Pitzalis M, Pala M, Menzel S, Metrustry S, Spector TD, Leoni L, Angius A, Uda M, Moi P, Thein SL, Galanello R, Abecasis GR, Schlessinger D, Sanna S, Cucca F.

Nat Genet. 2015 Nov;47(11):1264-71. doi: 10.1038/ng.3307. Epub 2015 Sep 14.

9.

Thalassemia major between liver and heart: Where we are now.

Dessì C, Leoni G, Moi P, Danjou F, Follesa I, Foschini ML, Morittu M, Zappu A, Defraia E, Bina P, Cunico A, Civolani A, Podda RA, Origa R.

Blood Cells Mol Dis. 2015 Jun;55(1):82-8. doi: 10.1016/j.bcmd.2015.03.010. Epub 2015 Apr 6.

PMID:
25976473
10.

IFNL3 polymorphisms and HCV infection in patients with beta thalassemia.

Origa R, Marceddu G, Danjou F, Perseu L, Satta S, Demartis FR, Piga A, Longo F, Lai ME, Vacquer S, Galanello R.

Ann Hepatol. 2015 May-Jun;14(3):389-95.

11.

Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and β-thalassemia intermedia.

Origa R, Cazzola M, Mereu E, Danjou F, Barella S, Giagu N, Galanello R, Swinkels DW.

Haematologica. 2015 May;100(5):e169-71. doi: 10.3324/haematol.2014.115733. Epub 2015 Jan 16. No abstract available.

12.

A genetic score for the prediction of beta-thalassemia severity.

Danjou F, Francavilla M, Anni F, Satta S, Demartis FR, Perseu L, Manca M, Sollaino MC, Manunza L, Mereu E, Marceddu G, Pissard S, Joly P, Thuret I, Origa R, Borg J, Forni GL, Piga A, Lai ME, Badens C, Moi P, Galanello R.

Haematologica. 2015 Apr;100(4):452-7. doi: 10.3324/haematol.2014.113886. Epub 2014 Dec 5.

13.

Rare variant genotype imputation with thousands of study-specific whole-genome sequences: implications for cost-effective study designs.

Pistis G, Porcu E, Vrieze SI, Sidore C, Steri M, Danjou F, Busonero F, Mulas A, Zoledziewska M, Maschio A, Brennan C, Lai S, Miller MB, Marcelli M, Urru MF, Pitzalis M, Lyons RH, Kang HM, Jones CM, Angius A, Iacono WG, Schlessinger D, McGue M, Cucca F, Abecasis GR, Sanna S.

Eur J Hum Genet. 2015 Jul;23(7):975-83. doi: 10.1038/ejhg.2014.216. Epub 2014 Oct 8.

14.

Influence of allograft weight to recipient bodyweight ratio on outcome of cadaveric renal transplantation.

Codas R, Danjou F, Dagot C, Martin X, Morelon E, Badet L, Hanf W, Petruzzo P.

Nephrology (Carlton). 2014 Jul;19(7):420-5. doi: 10.1111/nep.12277.

PMID:
24802649
15.

A decisional algorithm to start iron chelation in patients with beta thalassemia.

Danjou F, Cabantchik ZI, Origa R, Moi P, Marcias M, Barella S, Defraia E, Dessì C, Foschini ML, Giagu N, Leoni GB, Morittu M, Galanello R.

Haematologica. 2014 Mar;99(3):e38-40. doi: 10.3324/haematol.2013.098202. No abstract available.

16.

Anti-actin IgA antibodies identify celiac disease patients with a Marsh 3 intestinal damage among subjects with moderate anti-TG2 levels.

Schirru E, Danjou F, Cicotto L, Rossino R, Macis MD, Lampis R, Jores RD, Congia M.

Biomed Res Int. 2013;2013:630463. doi: 10.1155/2013/630463. Epub 2013 Sep 5.

17.

Impact of heart magnetic resonance imaging on chelation choices, compliance with treatment and risk of heart disease in patients with thalassaemia major.

Origa R, Danjou F, Cossa S, Matta G, Bina P, Dessì C, Defraia E, Foschini ML, Leoni G, Morittu M, Galanello R.

Br J Haematol. 2013 Nov;163(3):400-3. doi: 10.1111/bjh.12517. Epub 2013 Aug 16.

PMID:
24033185
18.

Longitudinal analysis of heart and liver iron in thalassemia major patients according to chelation treatment.

Danjou F, Origa R, Anni F, Saba L, Cossa S, Podda G, Galanello R.

Blood Cells Mol Dis. 2013 Oct;51(3):142-5. doi: 10.1016/j.bcmd.2013.06.001. Epub 2013 Jun 28.

PMID:
23816436
19.

Natural history of hepatitis C in thalassemia major: a long-term prospective study.

Lai ME, Origa R, Danjou F, Leoni GB, Vacquer S, Anni F, Corrias C, Farci P, Congiu G, Galanello R.

Eur J Haematol. 2013 Jun;90(6):501-7. doi: 10.1111/ejh.12086. Epub 2013 Mar 14.

PMID:
23414443
20.

Seventy-five genetic loci influencing the human red blood cell.

van der Harst P, Zhang W, Mateo Leach I, Rendon A, Verweij N, Sehmi J, Paul DS, Elling U, Allayee H, Li X, Radhakrishnan A, Tan ST, Voss K, Weichenberger CX, Albers CA, Al-Hussani A, Asselbergs FW, Ciullo M, Danjou F, Dina C, Esko T, Evans DM, Franke L, Gögele M, Hartiala J, Hersch M, Holm H, Hottenga JJ, Kanoni S, Kleber ME, Lagou V, Langenberg C, Lopez LM, Lyytikäinen LP, Melander O, Murgia F, Nolte IM, O'Reilly PF, Padmanabhan S, Parsa A, Pirastu N, Porcu E, Portas L, Prokopenko I, Ried JS, Shin SY, Tang CS, Teumer A, Traglia M, Ulivi S, Westra HJ, Yang J, Zhao JH, Anni F, Abdellaoui A, Attwood A, Balkau B, Bandinelli S, Bastardot F, Benyamin B, Boehm BO, Cookson WO, Das D, de Bakker PI, de Boer RA, de Geus EJ, de Moor MH, Dimitriou M, Domingues FS, Döring A, Engström G, Eyjolfsson GI, Ferrucci L, Fischer K, Galanello R, Garner SF, Genser B, Gibson QD, Girotto G, Gudbjartsson DF, Harris SE, Hartikainen AL, Hastie CE, Hedblad B, Illig T, Jolley J, Kähönen M, Kema IP, Kemp JP, Liang L, Lloyd-Jones H, Loos RJ, Meacham S, Medland SE, Meisinger C, Memari Y, Mihailov E, Miller K, Moffatt MF, Nauck M, Novatchkova M, Nutile T, Olafsson I, Onundarson PT, Parracciani D, Penninx BW, Perseu L, Piga A, Pistis G, Pouta A, Puc U, Raitakari O, Ring SM, Robino A, Ruggiero D, Ruokonen A, Saint-Pierre A, Sala C, Salumets A, Sambrook J, Schepers H, Schmidt CO, Silljé HH, Sladek R, Smit JH, Starr JM, Stephens J, Sulem P, Tanaka T, Thorsteinsdottir U, Tragante V, van Gilst WH, van Pelt LJ, van Veldhuisen DJ, Völker U, Whitfield JB, Willemsen G, Winkelmann BR, Wirnsberger G, Algra A, Cucca F, d'Adamo AP, Danesh J, Deary IJ, Dominiczak AF, Elliott P, Fortina P, Froguel P, Gasparini P, Greinacher A, Hazen SL, Jarvelin MR, Khaw KT, Lehtimäki T, Maerz W, Martin NG, Metspalu A, Mitchell BD, Montgomery GW, Moore C, Navis G, Pirastu M, Pramstaller PP, Ramirez-Solis R, Schadt E, Scott J, Shuldiner AR, Smith GD, Smith JG, Snieder H, Sorice R, Spector TD, Stefansson K, Stumvoll M, Tang WH, Toniolo D, Tönjes A, Visscher PM, Vollenweider P, Wareham NJ, Wolffenbuttel BH, Boomsma DI, Beckmann JS, Dedoussis GV, Deloukas P, Ferreira MA, Sanna S, Uda M, Hicks AA, Penninger JM, Gieger C, Kooner JS, Ouwehand WH, Soranzo N, Chambers JC.

Nature. 2012 Dec 20;492(7429):369-75. doi: 10.1038/nature11677. Epub 2012 Dec 5.

21.

Genetic modifiers of β-thalassemia and clinical severity as assessed by age at first transfusion.

Danjou F, Anni F, Perseu L, Satta S, Dessì C, Lai ME, Fortina P, Devoto M, Galanello R.

Haematologica. 2012 Jul;97(7):989-93. doi: 10.3324/haematol.2011.053504. Epub 2012 Jan 22.

22.

Beta-thalassemia: from genotype to phenotype.

Danjou F, Anni F, Galanello R.

Haematologica. 2011 Nov;96(11):1573-5. doi: 10.3324/haematol.2011.055962. No abstract available.

23.

A randomized study comparing IGL-1 to the University of Wisconsin preservation solution in liver transplantation.

Dondéro F, Paugam-Burtz C, Danjou F, Stocco J, Durand F, Belghiti J.

Ann Transplant. 2010 Oct-Dec;15(4):7-14.

PMID:
21183870
24.

Combined iron chelation therapy.

Galanello R, Agus A, Campus S, Danjou F, Giardina PJ, Grady RW.

Ann N Y Acad Sci. 2010 Aug;1202:79-86. doi: 10.1111/j.1749-6632.2010.05591.x.

PMID:
20712777
25.

Predictive factors for persistent use and compliance of immediate-release methylphenidate: a 36-month naturalistic study.

Atzori P, Usala T, Carucci S, Danjou F, Zuddas A.

J Child Adolesc Psychopharmacol. 2009 Dec;19(6):673-81. doi: 10.1089/cap.2008.0146.

PMID:
20035585
26.

IGL-1 solution in kidney transplantation: first multi-center study.

Codas R, Petruzzo P, Morelon E, Lefrançois N, Danjou F, Berthillot C, Contu P, Espa M, Martin X, Badet L.

Clin Transplant. 2009 Jun-Jul;23(3):337-42. doi: 10.1111/j.1399-0012.2009.00959.x. Epub 2009 Feb 5.

PMID:
19210685
27.

Impact of pancreatic venous drainage site on long-term patient and graft outcome in simultaneous pancreas-kidney transplantation.

Petruzzo P, Lefrancois N, Berthillot C, Danjou F, Contu P, Codas R, Morelon E, Dubernard JM, Martin X, Badet L.

Clin Transplant. 2008 Jan-Feb;22(1):107-12. doi: 10.1111/j.1399-0012.2007.00773.x.

PMID:
18217911
28.

Kidney preservation with IGL-1 solution: a preliminary report.

Badet L, Petruzzo P, Lefrançois N, McGregor B, Espa M, Berthillot C, Danjou F, Contu P, Aissa AH, Virieux SR, Colpart JJ, Martin X.

Transplant Proc. 2005 Jan-Feb;37(1):308-11.

PMID:
15808627

Supplemental Content

Loading ...
Support Center